Landiolol in Postoperative Atrial Fibrillation

PHASE3CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

January 17, 2019

Primary Completion Date

December 4, 2019

Study Completion Date

December 4, 2019

Conditions
Atrial Fibrillation
Interventions
DRUG

Landiolol

Landiolol perfusion over 120 minutes in incremental doses : 0.5, 1, 2, 5 and 10 µg/kg/min. Doses are modified every 20 minutes

DRUG

Placebo

Placebo perfusion is sodium chloride NaCl 0.9% over 120 minutes in incremental doses : 0.03, 0.06, 0.12, 0.3 and 0.6 mL/kg/h. Doses are modified every 20 minutes. Perfusion are similar in landiolol group to preserve blind.

Trial Locations (1)

Unknown

Hôpital Louis Pradel, Bron

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER

NCT03779178 - Landiolol in Postoperative Atrial Fibrillation | Biotech Hunter | Biotech Hunter